TP53 and sarcoma: In the low NNMT level group, TP53 mutations were more prevalent than in the high expression group, with the exception of sarcoma (SARC); mutation events were more common in the high NNMT level group for LGG, SARC, BLCA, KIRP, UCEC, COAD, and ESCA.